BioXcel: With IPO, BioXcel Looks to Fund AI-Fueled Drug Discovery Work

Using software to speed up drug discovery isn't a new idea, but it's generating more interest thanks to artificial intelligence. BioXcel Therapeutics is trying to parlay that momentum into an initial public stock offering to fund human studies on a pair of drugs it found with the help of AI. Branford, CT-based BioXcel set a [...]